David A Cabral Selected Research

David A Cabral Research Topics

Disease

12	Vasculitis (Vasculitides) 05/2022 - 11/2009
12	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2022 - 10/2002
9	Arthritis (Polyarthritis) 01/2021 - 01/2004
6	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 05/2022 - 11/2009
6	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 05/2022 - 11/2009
6	Inflammation (Inflammations) 01/2022 - 01/2018
6	Rheumatic Diseases (Rheumatism) 07/2020 - 04/2005
5	Microscopic Polyangiitis 05/2022 - 11/2009
4	Systemic Vasculitis 01/2020 - 04/2005
3	Osteoporosis 11/2021 - 09/2015
3	Pain (Aches) 01/2018 - 04/2004
3	Glomerulonephritis 01/2017 - 11/2009
3	Churg-Strauss Syndrome (Allergic Angiitis) 01/2017 - 11/2009
2	Renal Insufficiency (Renal Failure) 05/2022 - 09/2004
2	Osteoporotic Fractures 11/2021 - 11/2021
2	Psoriatic Arthritis 01/2021 - 08/2009
2	Fever (Fevers) 11/2013 - 09/2004
1	Virus Diseases (Viral Diseases) 07/2020
1	Uveitis 11/2019
1	Hemorrhage 10/2016
1	Aphthous Stomatitis (Aphthous Ulcer) 11/2013
1	Lymphadenitis (Adenitis) 11/2013
1	Pharyngitis (Sore Throat) 11/2013
1	Abdominal Pain (Pain, Abdominal) 11/2013
1	Leukemia 08/2012
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2012
1	Back Pain (Backache) 01/2012
1	Dermatomyositis (Dermatopolymyositis) 04/2005
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2005
1	Macrophage Activation Syndrome 09/2004
1	Hepatitis 09/2004
1	Exanthema (Rash) 09/2004
1	Thrombotic Thrombocytopenic Purpura 09/2004
1	Nausea 01/2004
1	Rheumatoid Arthritis 03/2003
1	Central Nervous System Diseases (CNS Diseases) 01/2003
1	Spondylarthropathies 10/2002

Drug/Important Bio-Agent (IBA)

10	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 11/2009
8	Rheumatoid FactorIBA 01/2021 - 10/2002
6	GlucocorticoidsIBA 05/2022 - 01/2012
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
5	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2017 - 09/2004
4	sulfated polyvinyl alcoholIBA 01/2020 - 10/2013
4	Prostaglandins AIBA 01/2018 - 04/2004
3	S100A12 ProteinIBA 01/2022 - 01/2018
2	C-Reactive ProteinIBA 01/2022 - 01/2020
2	Biological ProductsIBA 01/2020 - 01/2016
2	Antinuclear AntibodiesIBA 11/2019 - 01/2016
2	Antirheumatic Agents (DMARD)IBA 01/2016 - 10/2015
2	CalciumIBA 01/2012 - 04/2005
2	Methotrexate (Mexate)FDA LinkGeneric 12/2004 - 01/2004
1	chlorotriphenylsilane (CTPS)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Cytidine Triphosphate (CTP)IBA 01/2022
1	SteroidsIBA 11/2021
1	Zoledronic Acid (Zometa)FDA Link 11/2021
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	EnzymesIBA 07/2020
1	CreatinineIBA 01/2020
1	AutoantibodiesIBA 01/2020
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 10/2019
1	CytokinesIBA 10/2019
1	Interferon Type IIBA 10/2019
1	InterferonsIBA 10/2019
1	Adenosine DeaminaseIBA 10/2019
1	Myeloblastin (Proteinase 3)IBA 01/2018
1	Oxygen (Dioxygen)IBA 10/2016
1	Annexin A5IBA 11/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2013
1	LuminolIBA 11/2013
1	Galectin 3 (LGALS3)IBA 11/2013
1	isoluminolIBA 11/2013
1	Etanercept (Enbrel)FDA Link 10/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2012
1	Vitamin D FDA LinkGeneric 01/2012
1	ametantrone (HAQ)IBA 08/2009
1	Naproxen (Naprosyn)FDA LinkGeneric 09/2004
1	EpitopesIBA 03/2003
1	AntibodiesIBA 01/2003

Therapy/Procedure

3	Therapeutics 01/2022 - 04/2010
2	Plasmapheresis 05/2022 - 09/2004
2	Transitional Care 08/2007 - 04/2005
1	Remission Induction 05/2022
1	Pain Management 01/2018
1	Injections 10/2015
1	Biological Therapy 09/2012